Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Junsoo Park 2 Articles
Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants
Junsoo Park , Rackhyun Park , Minsu Jang , Yea-In Park , Yeonjeong Park
J. Microbiol. 2022;60(3):347-354.   Published online January 28, 2022
DOI: https://doi.org/10.1007/s12275-022-1499-z
  • 975 View
  • 3 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Coronavirus disease (COVID-19) can cause critical conditions that require efficient therapeutics. Several medicines are derived from plants, and researchers are seeking natural compounds to ameliorate the symptoms of COVID-19. Viral enzymes are popular targets of antiviral medicines; the genome of coronaviruses encodes several enzymes, including RNAdependent RNA polymerase and viral proteases. Various screening systems have been developed to identify potential inhibitors. In this review, we describe the natural compounds that have been shown to exert inhibitory effects on coronavirus enzymes. Although computer-aided molecular structural studies have predicted several antiviral compound candidates, the current review focuses on experimentally proven natural compounds.

Citations

Citations to this article as recorded by  
  • Green Synthesis and Quality-by-Design Optimization of Dacryodes edulis-Derived Silver Nanoparticles with Broad-Spectrum Antiviral and Antimicrobial Activity
    Jabulile H. Xulu, Vuyelwa J. Tembu, Sharon Moeno, Bienvenu Tsakem, Vuyisile S. Thibane, Bwalya A. Witika, Xavier Siwe Noundou
    Molecules.2026; 31(11): 1821.     CrossRef
  • Green Tea Catechins and COVID-19: Epidemiological Trends and Therapeutic Perspectives
    Maksim Storozhuk
    Current Pharmaceutical Design.2026; 32(20): 1612.     CrossRef
  • Natural Inhibitors Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease From Three Vietnamese Bryophytes
    Thi‐Kim‐Dung Le, Gia‐Hai Mach, Nguyen‐Khanh‐Trinh Tram, Nguyen‐Kim‐Tuyen Pham, Ngoc‐Khanh‐Van Nguyen, Thi‐Minh‐Dinh Tran, Boi‐Phong Vuong, Ngoc‐Hong Nguyen, Thuc‐Huy Duong, Kiattawee Choowongkomon
    Chemistry & Biodiversity.2025;[Epub]     CrossRef
  • Eupatin, a Flavonoid, Inhibits Coronavirus 3CL Protease and Replication
    Yea-In Park, Jang Hoon Kim, Siyun Lee, Ik Soo Lee, Junsoo Park
    International Journal of Molecular Sciences.2023; 24(11): 9211.     CrossRef
  • Structural Insights into Plasticity and Discovery of Flavonoid Allosteric Inhibitors of Flavivirus NS2B–NS3 Protease
    Marielena Vogel Saivish, Gabriela de Lima Menezes, Vivaldo Gomes da Costa, Liliane Nebo, Gislaine Celestino Dutra da Silva, Carolina Colombelli Pacca, Rafael Elias Marques, Maurício Lacerda Nogueira, Roosevelt Alves Da Silva
    Biophysica.2023; 3(1): 71.     CrossRef
  • Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
    Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, Uddhab Karki, Jianfeng Xu
    Life.2023; 13(3): 617.     CrossRef
  • Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus
    Chirag N. Patel, Siddhi P. Jani, Sivakumar Prasanth Kumar, Krunal M. Modi, Yogesh Kumar
    Computers in Biology and Medicine.2022; 151: 106318.     CrossRef
  • Two years of COVID-19 pandemic: where are we now?
    Jinjong Myoung
    Journal of Microbiology.2022; 60(3): 235.     CrossRef
  • Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity
    Chang Liu, Tess Puopolo, Huifang Li, Ang Cai, Navindra P. Seeram, Hang Ma
    Molecules.2022; 27(18): 6127.     CrossRef
  • Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases
    Anand Gaurav, Neetu Agrawal, Mayasah Al-Nema, Vertika Gautam
    Current Topics in Medicinal Chemistry.2022; 22(26): 2190.     CrossRef
Kaposi’s Sarcoma-Associated Herpesvirus Viral Protein Kinase Interacts with RNA Helicase A and Regulates Host Gene Expression
Jae Eun Jong , Junsoo Park , Sunmi Kim , Taegun Seo
J. Microbiol. 2010;48(2):206-212.   Published online May 1, 2010
DOI: https://doi.org/10.1007/s12275-010-0021-1
  • 688 View
  • 1 Download
  • 9 Crossref
AbstractAbstract PDF
RNA helicase A (RHA) containing the DExH motif is a human homolog of maleless protein that regulates expression of genes located in the Drosophila X chromosome during dosage compensation. RHA exerts helicase activity that unwinds double-stranded RNA and DNA to a single-strand form. The protein acts as a bridging factor mediating interactions of CBP/p300 and RNA pol II, and consequently affects gene expression. Kaposi’s sarcoma-associated herpesvirus (KSHV) is a member of the γ-herpesvirus subfamily that causes several disorders. The majority of herpesviruses commonly encode predicted viral protein kinases. KSHV open reading frame 36 (ORF36) codes for protein kinase domains, and functions as a serine/threonine protein kinase. KSHV ORF36 is classified as a late gene, as it is expressed during lytic replication and localized in the nuclei of KSHV-infected cells. Recent studies show that viral protein kinase (vPK) interacts with cellular proteins. In this study, we determined the cellular localization of vPK in KSHVinfected BCBL-1 cells using confocal microscopy. Proteomic analysis indicates that cellular proteins interacted with vPK, and co-immunoprecipitation reactions further reveal interactions between vPK and RHA. Moreover, KSHV vPK appeared to regulate the transcriptional activation of Cre promoter, and plays an important role in cellular transcription of RHA.

Citations

Citations to this article as recorded by  
  • Population Genetic Structure and Human Adaptation of Kaposi Sarcoma–Associated Herpesvirus
    Alessandra Mozzi, Diego Forni, Rachele Cagliani, Cristian Molteni, Mario Clerici, Manuela Sironi
    Open Forum Infectious Diseases.2025;[Epub]     CrossRef
  • RNA helicase A as co-factor for DNA viruses during replication
    Fan Guo, Li Xing
    Virus Research.2021; 291: 198206.     CrossRef
  • Mechanism of Angiopoietin-1 Upregulation in Kaposi's Sarcoma-Associated Herpesvirus-Infected PEL Cell Lines
    Xin Zheng, Eriko Ohsaki, Keiji Ueda, R. M. Longnecker
    Journal of Virology.2015; 89(9): 4786.     CrossRef
  • The Expanding Functions of Cellular Helicases: The Tombusvirus RNA Replication Enhancer Co-opts the Plant eIF4AIII-Like AtRH2 and the DDX5-Like AtRH5 DEAD-Box RNA Helicases to Promote Viral Asymmetric RNA Replication
    Nikolay Kovalev, Peter D. Nagy, Lee Gehrke
    PLoS Pathogens.2014; 10(4): e1004051.     CrossRef
  • A Co-Opted DEAD-Box RNA Helicase Enhances Tombusvirus Plus-Strand Synthesis
    Nikolay Kovalev, Judit Pogany, Peter D. Nagy, Shou-Wei Ding
    PLoS Pathogens.2012; 8(2): e1002537.     CrossRef
  • Application of Proteomics to Soft Tissue Sarcomas
    Tadashi Kondo, Daisuke Kubota, Akira Kawai
    International Journal of Proteomics.2012; 2012: 1.     CrossRef
  • Similar roles for yeast Dbp2 and Arabidopsis RH20 DEAD-box RNA helicases to Ded1 helicase in tombusvirus plus-strand synthesis
    Nikolay Kovalev, Daniel Barajas, Peter D. Nagy
    Virology.2012; 432(2): 470.     CrossRef
  • The function and architecture of DEAH/RHA helicases
    Yangzi He, Gregers R. Andersen, Klaus H. Nielsen
    bmc.2011; 2(4): 315.     CrossRef
  • Recognition of herpesviruses by the innate immune system
    Søren R. Paludan, Andrew G. Bowie, Kristy A. Horan, Katherine A. Fitzgerald
    Nature Reviews Immunology.2011; 11(2): 143.     CrossRef
Junsoo Park 0 Article

Journal of Microbiology : Journal of Microbiology
TOP